FIELD: pharmacology.
SUBSTANCE: invention relates to a compound of the formula: 
, and also to pharmaceutical compositions and methods for treatment and prevention of a disease such as thrombotic one.
EFFECT: new compounds capable of inhibiting the protease activity of thrombin.
15 cl, 3 tbl, 85 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MULTISUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS | 2014 |
|
RU2678830C2 |
| SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-7-YL COMPOUNDS AS THE INHIBITORS OF PDE2 | 2015 |
|
RU2659070C9 |
| IMPROVED APELIN RECEPTOR AGONISTS (APJ) AND THEIR USE | 2016 |
|
RU2766148C1 |
| COMPOUND BASED ON DIHYDRONAPTHYRIDINONE, METHOD OF ITS OBTAINING, AND ITS USE IN MEDICINE | 2021 |
|
RU2809869C1 |
| CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
| PHENOXYMETHYL DERIVATIVES | 2016 |
|
RU2746481C1 |
| HER2 MUTATION INHIBITORS | 2022 |
|
RU2834124C2 |
| DERIVATIVES OF 5-MEMBER HETEROCYCLES AS KINASE p38 INHIBITORS | 2004 |
|
RU2381219C2 |
| PROTEIN KINASE INHIBITORS FOR ENHANCING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | 2019 |
|
RU2822216C2 |
| COMPOUND HAVING INHIBITORY ACTIVITY ON KDM5, AND PHARMACEUTICAL USE THEREOF | 2021 |
|
RU2840256C1 |
